Organization
Toronto Stock Venture Exchange (TSXV)
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Toronto Stock Venture Exchange (TSXV)
... following issues have been halted by IIROC: Company: CHC Student Housing Corp. TSX-Venture Symbol: CHC Reason: At the Request of the Company Pending News Halt ...
... 14.6% discount to the close price on Canadian Venture. + Canadian Venture: KALY.TSXV 5,443,530 [VI of 3.5] volume 97.55% of aggregate. Price: 38.0c. [Volume Index ...
... was 1.7 times average trading of 1.1 million shares. + Canadian Venture: MKA.TSXV 7,000 [VI of 0.2] volume 0.38% of aggregate. Price: 16.50c. + London: ...
... Medical Group Inc. ("CMGI") and receipt of final approval from the TSX Venture Exchange ("TSXV"), as previously announced on December 21, 2017. "Liberty Biopharma is ...
... CAD65.1 million (US$52.1 million). SECTION 7 STOCK BUZZ Corporate Wire Subject to TSXV approval, the Company's normal course bid will commence December 23, 2017. FORT ...
... today announced its financing activity on Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV) for December 2017. Toronto Stock Exchange, TSX Venture Exchange TORONTO, ...
... STATES INDIVA Corporation ("INDIVA" or the "Company") and Rainmaker Resources Ltd. ("Rainmaker") (TSX VENTURE:RIR) are pleased to announce that a Filing Statement dated as of ...
... of shareholders held in Toronto today (the "Meeting"). Subject to final TSX Venture Exchange approval, it is anticipated that investments of Pound5 million (comprising Pound2 ...
... Company announces that it has requested a 30-day extension from the TSX Venture Exchange ('TSXV') to close its private placement of convertible debentures (the 'Debentures') ...
... ("CSE") and intends to voluntarily delist the Common Shares from the TSX Venture Exchange ("TSXV"). Delisting of the Common Shares from the TSXV is anticipated ...
... Medical Group Inc. ("CMGI") and receipt of final approval from the TSX Venture Exchange ("TSXV"), as previously announced on December 21, 2017. "Liberty Biopharma is ...
... CAD66.9 million (US$53.8 million). SECTION 7 STOCK BUZZ Corporate Wire Subject to TSXV approval, the Company's normal course bid will commence December 23, 2017. FORT ...
... today announced its financing activity on Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV) for December 2017. Toronto Stock Exchange, TSX Venture Exchange TORONTO, ...
... intended to constitute Adent's "Qualifying Transaction" pursuant Policy 2.4 of the TSX Venture Exchange ("TSXV"). The Offering Khiron completed the Offering of Subscription Receipts pursuant ...
... 18.1% discount to the close price on Canadian Venture. + Canadian Venture: NDVA.TSXV 405,584 [VI of 14.7] volume 99.89% of aggregate. Price: CAD1.28. [Volume Index ...
... volume was 1.4 times average trading of 993,000 shares. + Canadian Venture: MKA.TSXV 48,050 [VI of 1.7] volume 3.53% of aggregate. Price: 14.50c. + London: ...
... 6.2% discount to the close price on Canadian Venture. + Canadian Venture: KALY.TSXV 1,574,456 [VI of 1.0] volume 86.35% of aggregate. Price: 34.50c. [Volume Index ...
... Medical Group Inc. ("CMGI") and receipt of final approval from the TSX Venture Exchange ("TSXV"), as previously announced on December 21, 2017. "Liberty Biopharma is ...
... of the Corporation's stock option plan and the requirements of the TSX Venture Exchange. Following this grant of options, the Corporation has a total of ...
Want to see the full history on Toronto Stock Venture Exchange (TSXV)? Upgrade to RelSci Pro now!
Start My Free Trial